8-K
filed April 29, 2024, 7:59 PM ET
CIK 0001008586
earnings
confidence high
sentiment neutral
materiality 0.70
STREAMLINE HEALTH SOLUTIONS INC.: Nasdaq/NYSE listing notice — Streamline Health Q4 rev $5.4M, net loss improves; Nasdaq extends bid price compliance to Oct 2024
STREAMLINE HEALTH SOLUTIONS INC.
- Q4 FY2023 revenue $5.4M (down 19% YoY); net loss ($1.4M) vs ($2.2M) prior year; adjusted EBITDA $0.4M vs ($0.2M).
- Full-year FY2023 revenue $22.6M (down 9% YoY); net loss ($18.7M) including $10.8M impairment; adjusted EBITDA loss improved to ($1.4M) from ($3.8M).
- SaaS revenue grew $1.7M YoY; booked SaaS ACV $15.6M as of April 29, 2024, above adjusted EBITDA breakeven run rate of $15.5M.
- Nasdaq granted additional 180-day period until Oct 21, 2024 to regain minimum bid price of $1.00 per share.
- Bryant J. Reeves III appointed permanent CFO effective April 29, 2024; base salary increased to $225K; CEO Stilwill salary increased to $375K; both granted restricted stock.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
STREAMLINE HEALTH SOLUTIONS INC. reported the twelve months ended January 31, 2024 results: revenue $22.6 million, net income ($18.7 million). Guidance reaffirmed.
- Period
- the twelve months ended January 31, 2024
- Revenue
- $22.6 million
- Net income
- ($18.7 million)
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
For the twelve months ended January 31, 2024, revenue totaled $22.6 million as compared to $24.9 million during fiscal 2022.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
STREAMLINE HEALTH SOLUTIONS INC. reported the fourth quarter of fiscal 2023 results: revenue $5.4 million, net income ($1.4 million). Guidance reaffirmed.
- Period
- the fourth quarter of fiscal 2023
- Revenue
- $5.4 million
- Net income
- ($1.4 million)
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
Total revenue for the fourth quarter of fiscal 2023 was $5.4 million as compared to $6.7 million during the fourth quarter of fiscal 2022.
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.82
STREAMLINE HEALTH SOLUTIONS INC. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
- Exchange
- nasdaq
- Notice
- compliance regained
- Deficiency
- minimum bid price
- Rules
- 5550(a)(2), 5810(c)(3)(A)
Exact text from the filing
April 22, 2024, to regain compliance with the Minimum Bid Price Requirement. On April 23, 2024, the Company received a letter from the Staff informing the Company that, while the Company has not regained compliance with the Minimum Bid Price Requirement, the Staff has determined that the Company is eligible for an additional 180 calendar day period, or until October 21, 2024 (the “Second Compliance Period”), to regain compliance. If at any time during the Second Compliance Period, the closing bid price of the Common Stock is at least $1.00 per share for a minimum of 10 consecutive business day
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Bryant J. Reeves, III was appointed as Chief Financial Officer at STREAMLINE HEALTH SOLUTIONS INC..
- Action
- appointed
- Role
- Chief Financial Officer
Exact text from the filing
On April 29, 2024, the Company appointed Bryant J. Reeves, III as the Company’s permanent Chief Financial Officer, effective April 29, 2024.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.